Expression of parvin-Β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract

British Journal of Cancer

Volumn 103, Issue 6, 2010, Pages 852-860

  Wu, C F ^a,b   Ng, K F ^a   Chen, C S ^a   Chang, P L ^a   Chuang, C K ^a   Weng, W H ^c   Liao, S K ^b,d   Pang, S T ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

parvin ; prognostic factor; upper urinary tract; urothelial cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; DOXYCYCLINE; MESSENGER RNA; PARVIN BETA; PLASMID DNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ACTININ; PARVB PROTEIN, HUMAN; PRIMER DNA; TUMOR MARKER;

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARVIN BETA GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TUMOR SUPPRESSOR GENE; URETER CARCINOMA; UROTHELIAL CELL CARCINOMA; WESTERN BLOTTING; BLADDER TUMOR; CELL DIVISION; CELL MOTION; CHEMISTRY; GENE SILENCING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SURVIVAL; UROTHELIUM;

ACTININ; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; CELL MOVEMENT; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 77956446943     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605835     Document Type: Article

References (45)

1. Assi K, Mills J, Owen D, Ong C, St Arnaud R, Dedhar S, Salh B (2008) Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis. Gut 57(7): 931-940
2. Bamias A, Deliveliotis C, Fountzilas G, Gika D, Anagnostopoulos A, Zorzou MP, Kastritis E, Constantinides C, Kosmidis P, Dimopoulos MA (2004) Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22(11): 2150-2154 (Pubitemid 41095148)
3. Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 208(1): 91-99
4. Castells A, Gusella JF, Ramesh V, Rustgi AK (2000) A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 60(11): 2836-2839
5. Charbit L, Gendreau MC, Mee S, Cukier J (1991) Tumors of the upper urinary tract: 10 years of experience. J Urol 146(5): 1243-1246
6. Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY, Park SH, Song HG (1998) ILK (beta1-integrin-linked protein kinase): a novel immuno-histochemical marker for Ewing s sarcoma and primitive neuroecto-dermal tumour. Virchows Arch 433(2): 113-117
7. Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R (1995) Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 46(6): 796-800
8. Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172(4, Part 1): 1271-1275
9. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12): 1435-1448
10. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH (2001) Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7(7): 1987-1991
11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC Cancer Staging Manual. 6th edn. Springer-Verlag: New York
12. Guinan P, Vogelzang NJ, Randazzo R, Sener S, Chmiel J, Fremgen A, Sylvester J (1992) Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40(5): 393-399
13. Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10): 816-826
14. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52(4): 594-601
15. Hannigan G, Troussard AA, Dedhar S (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5(1): 51-63
16. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6): 673-687
17. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W (2003) Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch 442(2): 118-123
18. Johnstone CN, Mongroo PS, Rich AS, Schupp M, Bowser MJ, Delemos AS, Tobias JW, Liu Y, Hannigan GE, Rustgi AK (2008) Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator- activated receptor gamma 1 phosphorylation. Mol Cell Biol 28(2): 687-704
19. Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98(8): 1620-1626
20. Kim YB, Lee SY, Ye SK, Lee JW (2007) Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells. Am J Physiol Cell Physiol 292(2): C857-C866
21. Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47(2): 155-169
22. Korenbaum E, Olski TM, Noegel AA (2001) Genomic organization and expression profile of the parvin family of focal adhesion proteins in mice and humans. Gene 279(1): 69-79
23. Krogh J, Kvist E, Rye B (1991) Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br J Urol 67(1): 32-36
24. Kwak C, Lee SE, Jeong IG, Ku JH (2006) Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68(1): 53-57
25. Lee JW, Juliano R (2004) Mitogenic signal transduction by integrin-and growth factor receptor-mediated pathways. Mol Cells 17(2): 188-202
26. Legate KR, Montanez E, Kudlacek O, Fassler R (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7(1): 20-31
27. Lerner SE, Blute ML, Richardson RL, Zincke H (1996) Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc 71(10): 945-950
28. Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54(5): 1127-1134
29. Maulard-Durdux C, Dufour B, Hennequin C, Chretien Y, Vignes B, Droz D, Delanian S, Housset M (1996) Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol 155(1): 115-117 (Pubitemid 126426443)
30. Mishima W, Suzuki A, Yamaji S, Yoshimi R, Ueda A, Kaneko T, Tanaka J, Miwa Y, Ohno S, Ishigatsubo Y (2004) The first CH domain of affixin activates Cdc42 and Rac1 through alphaPIX, a Cdc42/Rac1-specific guanine nucleotide exchanging factor. Genes Cells 9(3): 193-204
31. Mongroo PS, Johnstone CN, Naruszewicz I, Leung-Hagesteijn C, Sung RK, Carnio L, Rustgi AK, Hannigan GE (2004) Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer. Oncogene 23(55): 8959-8970
32. Nikolopoulos SN, Turner CE (2001) Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem 276(26): 23499-23505
33. Olski TM, Noegel AA, Korenbaum E (2001) Parvin, a 42kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci 114(Part 3): 525-538
34. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97(7): 3207-3212
35. Racioppi M, D'Addessi A, Alcini A, Destito A, Alcini E (1997) Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 80(5): 707-711
36. Rosano L, Spinella F, Di Castro V, Dedhar S, Nicotra MR, Natali PG, Bagnato A (2006) Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol Cancer Ther 5(4): 833-842
37. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, Braun A, Pfeifer A, Yurchenco PD, Fassler R (2003) Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 17(7): 926-940
38. Sepulveda JL, Wu C (2006) The parvins. Cell Mol Life Sci 63(1): 25-35
39. Tu Y, Huang Y, Zhang Y, Hua Y, Wu C (2001) A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153(3): 585-598
40. Tu Y, Li F, Goicoechea S, Wu C (1999) The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 19(3): 2425-2434
41. Wong RP, Ng P, Dedhar S, Li G (2007) The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther 6(6): 1692-1700
42. Wu C, Dedhar S (2001) Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155(4): 505-510
43. Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida M, Kanamori H, Mohri H, Ohno S, Ishigatsubo Y (2001) A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153(6): 1251-1264
44. Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L (2005) Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer 113(4): 619-628
45. Zhang Y, Chen K, Tu Y, Wu C (2004) Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival. J Biol Chem 279(40): 41695-41705